TES-4207

N/A

Report date: 2024/11/14 10:11:57
NME

Base Information

Drug NameTES-4207
Drug Alias NameTES-4207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNR2F6 protein inhibitors
TargetsNR2F6 protein
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTES Pharma SRL
China Registration ClassN/A

Develop Information

Active CompaniesTES Pharma SRL
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A